Statin drugs may help patients with heart valve disease avoid surgery

November 19, 2002

ROCHESTER, Minn. -- A study by Mayo Clinic researchers indicates that narrowing of the heart's "exit valve" is less than half as likely to worsen in patients taking statin drugs, as compared with similar patients not taking the cholesterol-lowering medications. The findings, which could lead to the first nonsurgical treatment for aortic stenosis, are reported in the Nov. 20, 2002, issue of the Journal of the American College of Cardiology.

The aortic valve is the one-way gate between the heart's main pumping chamber and the rest of the body. In aortic stenosis, this valve becomes narrowed and causes the heart to work harder. The only treatment for severe aortic stenosis is surgical replacement of the valve.

A new understanding of the aortic stenosis disease process led to the statin study. "In the past few years there has been a total change in our way of thinking, because we realized that what was happening on the aortic valve was a phenomenon similar to atherosclerosis," says Maurice Sarano, M.D., the Mayo Clinic cardiologist who led the study. "Since the disease process is similar to what happens when plaques cause blockages in arteries, reducing the risk factors that lead to heart attack may also help keep the valve from narrowing."

Dr. Sarano and his colleagues screened all adults with aortic stenosis in Olmsted County, Minn. They measured the extent of aortic stenosis using ultrasound and then followed 156 patients for an average of 3.7 years. Because of the close association between high cholesterol and atherosclerosis, the researchers first looked for a link between cholesterol levels and worsening of aortic stenosis. "We were initially somewhat disappointed, because we saw absolutely no association," says Dr. Sarano.

However, when they compared changes in aortic stenosis measurements between the 38 patients who were taking cholesterol-lowering statin drugs and the 118 patients who were not on statin therapy, the statin-therapy patients had about half the rate of progression of the patients not treated with statins.

Dr. Sarano noted other studies have found statin therapy appears to improve the body's handling of calcium, increasing deposition of calcium in the bones, while decreasing potentially harmful calcium deposits in places such as heart valves. Therefore, he concluded, it is possible statins offer a triple benefit with regard to aortic stenosis by reducing cholesterol, inflammation and calcium deposition.

Dr. Sarano says the study's findings need to be confirmed in clinical trials. "While we are quite excited by the possibilities, I don't think we should immediately begin prescribing statins for these patients yet," he said. "We ought to formally test those medications in a clinical trial, so we can be more certain that statins do decrease the progression of aortic stenosis. If these findings are confirmed, we may be able to eliminate the need for valve replacement surgery in many patients."
-end-
Lee Aase
507-284-5005 (days)
507-284-2511 (evenings)
e-mail: newsbureau@mayo.edu

Mayo Clinic

Related Cholesterol Articles from Brightsurf:

Cholesterol's effects on cellular membranes
The findings have far-reaching implications in the general understanding of disease, the design of drug delivery methods, and many other biological applications that require specific assumptions about the role of cholesterol in cell membranes.

Autism-cholesterol link
Study identifies genetic link between cholesterol alterations and autism.

Microbes might manage your cholesterol
Researchers discover a link between human blood cholesterol levels and a gene in the microbiome that could one day help people manage their cholesterol through diet, probiotics, or entirely new types of treatment.

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov.

Rethinking how cholesterol is integrated into cells
Cholesterol is best known in connection with cardiovascular disease, but cholesterol is also vital for many fundamental processes in the body.

Seed oils are best for LDL cholesterol
Using a statistical technique called network meta-analysis, researchers have combined the results of dozens of studies of dietary oils to identify those with the best effect on patients' LDL cholesterol and other blood lipids.

Cholesterol leash: Key tethering protein found to transport cellular cholesterol
Cholesterol is an essential component of living organisms, but the mechanisms that transport cholesterol inside the cell are poorly understood.

New way to treat cholesterol may be on the horizon
A breakthrough discovery by scientists at Houston Methodist Research Institute could change the way we treat cholesterol.

How low should LDL cholesterol go?
New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to <10 mg/dL, safely results in additional lowering of risk of cardiovascular events.

Does boosting 'good' cholesterol really improve your health?
A new review addresses the mysteries behind 'good' HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients.

Read More: Cholesterol News and Cholesterol Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.